Swiss National Bank Ironwood Pharmaceuticals Inc Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Swiss National Bank holds 276,700 shares of IRWD stock, worth $924,178. This represents 0.0% of its overall portfolio holdings.

Number of Shares

276,700

Previous 276,700 -0.0%

Holding current value

$924,178

Previous $1.8 Million 36.97%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$8.79 - $11.51 $268,974 - $352,206	-30,600 Reduced 9.96%	276,700 $3.17 Million
Q3 2023 Nov 08, 2023	BUY	$8.25 - $11.35 $43,725 - $60,155	5,300 Added 1.75%	307,300 $2.96 Million
Q2 2023 Aug 09, 2023	BUY	$10.1 - $11.6 $40,400 - $46,400	4,000 Added 1.34%	302,000 $3.21 Million
Q1 2023 May 10, 2023	SELL	$10.37 - $12.56 $362,950 - $439,600	-35,000 Reduced 10.51%	298,000 $3.13 Million
Q4 2022 Feb 08, 2023	BUY	$9.9 - $12.43 $46,530 - $58,421	4,700 Added 1.43%	333,000 $4.13 Million
Q3 2022 Nov 09, 2022	SELL	$10.14 - $12.38 $94,302 - $115,134	-9,300 Reduced 2.75%	328,300 $3.4 Million
Q2 2022 Aug 09, 2022	SELL	$11.05 - $12.72 $331,500 - $381,600	-30,000 Reduced 8.16%	337,600 $3.89 Million
Q1 2022 May 09, 2022	BUY	$10.61 - $12.88 $292,836 - $355,488	27,600 Added 8.12%	367,600 $4.62 Million
Q3 2021 Nov 08, 2021	BUY	$11.92 - $13.92 $34,568 - $40,368	2,900 Added 0.86%	340,000 $4.44 Million
Q2 2021 Aug 06, 2021	SELL	$10.16 - $13.11 $105,664 - $136,344	-10,400 Reduced 2.99%	337,100 $4.34 Million
Q1 2021 May 07, 2021	BUY	$9.04 - $11.86 $38,871 - $50,998	4,300 Added 1.25%	347,500 $3.89 Million
Q3 2020 Nov 09, 2020	BUY	$8.99 - $10.74 $69,223 - $82,698	7,700 Added 2.3%	343,200 $3.09 Million
Q2 2020 Aug 05, 2020	BUY	$9.14 - $11.97 $286,996 - $375,858	31,400 Added 10.33%	335,500 $3.46 Million
Q1 2020 May 08, 2020	BUY	$8.58 - $14.01 $39,468 - $64,446	4,600 Added 1.54%	304,100 $3.07 Million
Q4 2019 Feb 06, 2020	BUY	$8.22 - $14.0 $61,650 - $105,000	7,500 Added 2.57%	299,500 $3.99 Million
Q3 2019 Nov 12, 2019	BUY	$8.59 - $10.96 $36,937 - $47,128	4,300 Added 1.49%	292,000 $2.51 Million
Q2 2019 Aug 02, 2019	BUY	$9.8 - $12.89 $317,520 - $417,636	32,400 Added 12.69%	287,700 $3.15 Million
Q1 2019 May 10, 2019	BUY	$8.27 - $12.73 $76,084 - $117,116	9,200 Added 3.74%	255,300 $3.45 Million
Q4 2018 Feb 13, 2019	SELL	$7.8 - $16.13 $143,520 - $296,792	-18,400 Reduced 6.96%	246,100 $2.55 Million
Q3 2018 Nov 08, 2018	BUY	$14.31 - $17.65 $374,922 - $462,429	26,200 Added 10.99%	264,500 $4.88 Million
Q2 2018 Aug 09, 2018	BUY	$11.83 - $16.2 $175,084 - $239,760	14,800 Added 6.62%	238,300 $4.56 Million
Q1 2018 May 04, 2018	BUY	$11.13 - $13.63 $54,537 - $66,787	4,900 Added 2.24%	223,500 $3.45 Million
Q4 2017 Feb 07, 2018	BUY	$12.16 - $14.58 $98,496 - $118,098	8,100 Added 3.85%	218,600 $3.28 Million
Q3 2017 Nov 03, 2017	BUY	$12.07 - $14.87 $2.54 Million - $3.13 Million	210,500	210,500 $3.32 Million

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $512M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Ironwood Pharmaceuticals Inc Transaction History